Ciprofloxacin decreases survival in HT‐29 cells via the induction of TGF‐β1 secretion and enhances the anti‐proliferative effect of 5‐fluorouracil

作者: Leonidas A Bourikas , George Kolios , Vassilis Valatas , George Notas , Ioannis Drygiannakis

DOI: 10.1111/J.1476-5381.2009.00161.X

关键词:

摘要: Background and purpose:  Fluoroquinolones are potent anti-microbial agents with multiple effects on host cells tissues. Previous studies have highlighted their pro-apoptotic effect human cancer an immunoregulatory role in animal models of inflammatory bowel disease. We examined the ciprofloxacin proliferation, cell cycle apoptosis HT-29 cells, a colonic epithelial line sensitive to transforming growth factor (TGF)-β1-mediated inhibition its TGF-β1 production. also proliferation combination 5-fluorouracil (5-FU), well-established agent. Experimental approach:  Using subconfluent cultures Caco-2 we studied ciprofloxacin, 5-FU apoptosis, necrosis cycle. The mRNA expression production was RNA extracts culture supernatants respectively, using confluent cultures. Key results:  Ciprofloxacin decreased concentration- time-dependent manner. This mediated by accumulation into S-phase but without any or necrosis. Additionally, enhanced antiproliferative 5-FU. Interestingly, found up-regulate anti-proliferative abolished when blocked. Confirming this mechanism further, had no Caco-2, that lacks functional receptors. Conclusions implications:  demonstrate novel intestinal via TGF-β1.

参考文章(46)
M G Bergeron, The pharmacokinetics and tissue penetration of the fluoroquinolones. Clinical and Investigative Medicine. ,vol. 12, pp. 20- 27 ,(1989)
Rik Derynck, Rosemary J. Akhurst, Allan Balmain, TGF-beta signaling in tumor suppression and cancer progression. Nature Genetics. ,vol. 29, pp. 117- 129 ,(2001) , 10.1038/NG1001-117
T C Rowe, D C Claire, J W Lawrence, V Weissig, Delayed cytotoxicity and cleavage of mitochondrial DNA in ciprofloxacin-treated mammalian cells. Molecular Pharmacology. ,vol. 50, pp. 1178- 1188 ,(1996)
Fazlul H. Sarkar, David P. Wood, Olivia Aranha, Ciprofloxacin Mediated Cell Growth Inhibition, S/G2-M Cell Cycle Arrest, and Apoptosis in a Human Transitional Cell Carcinoma of the Bladder Cell Line Clinical Cancer Research. ,vol. 6, pp. 891- 900 ,(2000)
E Rubinstein, E Somekh, N Shaked, D Douer, In vitro effects of ciprofloxacin and pefloxacin on growth of normal human hematopoietic progenitor cells and on leukemic cell lines. Journal of Pharmacology and Experimental Therapeutics. ,vol. 248, pp. 415- 418 ,(1989)
ASSUMPTA A. MADU, MARTIN MAYERS, RUTH PERKINS, WEIGUO LIU, GEORGE L. DRUSANO, RESHAM ASWANI, CHRISTIAN N. MADU, MICHAEL H. MILLER, Aqueous and Vitreous Penetration of Ciprofloxacin Following Different Modes of Systemic Administration Experimental Eye Research. ,vol. 63, pp. 129- 136 ,(1996) , 10.1006/EXER.1996.0101
Vassilis Valatas, George Kolios, Pinelopi Manousou, George Notas, Costas Xidakis, Ioannis Diamantis, Elias Kouroumalis, Octreotide regulates CC but not CXC LPS-induced chemokine secretion in rat Kupffer cells British Journal of Pharmacology. ,vol. 141, pp. 477- 487 ,(2004) , 10.1038/SJ.BJP.0705633
J. S. Wolfson, D. C. Hooper, Pharmacokinetics of quinolones: Newer aspects European Journal of Clinical Microbiology & Infectious Diseases. ,vol. 10, pp. 267- 274 ,(1991) , 10.1007/BF01967000
Theodore Miclau, Matthew L. Edin, Gayle E. Lester, Ronald W. Lindsey, Laurence E. Dahners, Effect of ciprofloxacin on the proliferation of osteoblast‐like MG‐63 human osteosarcoma cells in vitro Journal of Orthopaedic Research. ,vol. 16, pp. 509- 512 ,(1998) , 10.1002/JOR.1100160417
Brian Bierie, Harold L. Moses, Tumour microenvironment: TGFβ: the molecular Jekyll and Hyde of cancer Nature Reviews Cancer. ,vol. 6, pp. 506- 520 ,(2006) , 10.1038/NRC1926